期刊文献+

温针灸结合走罐法治疗寒冷性荨麻疹临床观察 被引量:10

Cold Urticaria Treated with Warm Needle Moxibustion Combined with Moving Cupping
下载PDF
导出
摘要 目的:观察温针灸结合背部膀胱经游走罐治疗原发性获得性寒冷性荨麻疹的临床疗效。方法:将86例患者随机分为两组,治疗组43例采用温针灸治疗,每日1次,同时结合背部膀胱经走罐,每周1次;对照组43例仅口服咪唑斯汀缓释片10 mg,1次/天,治疗4周一疗程;根据评分标准进行疗效比较。结果:治疗组有效率为88.37%,对照组为72.09%,两组比较差异有统计学意义(P<0.05);治疗组复发率13.04%,明显低于对照组(46.67%),差异有统计学意义(P<0.01)。结论:温针灸结合背部膀胱经游走罐治疗原发性获得性寒冷荨麻疹疗效显著,复发率低。 Objective:To observe the clinical effect on primary acquired cold urticaria treated with warm needle moxibustion combined with moving cupping along the bladder meridian. Methods:Eighty - six cases were ran- domly divided into two groups, treatment group included 43 eases, using warm needle moxibustion, once per day, and moving cupping along the bladder meridian, once per week;control group included 43 cases, using oral mizolastine sustained release tablets 10mg,once per day, four weeks as one session. According to the scoring criteria the efficacy was compared. Results:The effective rate was 88.37% in the treatment group ,and the ef- fective rate was 72.09% in the control group. The two groups were statistically significant(P 〈 0.05 ) ; the re- lapse rate of the treatment group ( 13.04% ) was lower than that in the control group (46.67%) , The two groups were statistically significant ( P 〈 0.01 ) ; Conclusion : Warm needle moxihustion combined with moving cupping along the bladder meridian is effective for treating primary acquired cold urticaria, and the relapse rate is lower.
作者 路瑶 姜忠磊
出处 《针灸临床杂志》 2014年第2期14-15,共2页 Journal of Clinical Acupuncture and Moxibustion
关键词 温针灸 走罐 寒冷性荨麻疹 Warm needle moxibustion Moving cupping, Cold urticaria
  • 相关文献

参考文献5

二级参考文献11

  • 1武水斗,伊书红.黄芪注射液穴位注射治疗获得性寒冷性荨麻疹[J].北京中医药大学学报(中医临床版),2005,12(6):14-15. 被引量:10
  • 2张宏誉,李宏,岳凤敏,王良录,方权,王瑞琦,秦万章,李明,金岚,秦立模,吴惠俐.咪唑斯汀治疗慢性特发性荨麻疹的多中心随机平行组对照的临床试验报告[J].中华微生物学和免疫学杂志,2001,21(S2):61-64. 被引量:11
  • 3[1]赵辨.临床皮肤病学.第2版.南京:江苏科学技术出版社,1983.615~616
  • 4[2]倪容之.现代皮肤病治疗学.北京:人民军医出版社,1999.391~396
  • 5Pichat P;Angel I;Arbilla S.Anti-inflammatory properties of mizolastine after oral administration on arachidonic acid-induced cutaneous reaction in the rat,1998(01).
  • 6Benavides J;Schoemaker H;Dana C.In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent,1995.
  • 7Dubertr;Murrieta Aguttes M;Tonet J.Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria:results of the MILOR Study[J],1999.
  • 8Sabbah A;Daele J;Wade AG.Comparison of the efficacy,safety,and onset of action of mizolastine,cetirizine,and placebo in the management of seasonal allergic rhinoconjunctivitis.MIZOCET Study Group[J],1999.
  • 9Leynadier F;Duarte-Risselin C;Murrieta M.Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria URTILOR study group,2000.
  • 10朱大勋.咪唑斯汀和四种常用H_1受体阻滞剂的实验抗组胺强度比较[J].中华皮肤科杂志,2001,34(3):219-220. 被引量:36

共引文献169

同被引文献229

引证文献10

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部